Immunome Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
IMNM on Nasdaq
Industry
Pharmaceutical Preparations
Location
18702 N. Creek Parkway, Suite 100, Bothell, WA

Insiders trading volume in the past year

Immunome Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Rapp Director $7.56M Oct 2, 2023
Clay B. Siegall President and CEO, Director $5.88M +$3.12M +113% Jul 29, 2025
Max Rosett Chief Financial Officer $760K Jul 29, 2025
John L. Lamattina Director $396K Jun 8, 2023
Franklyn G. Prendergast Director $360K Oct 2, 2023
Jean Jacques Bienaime Director $342K +$165K +93.5% Jun 10, 2025
Philip Tsai Chief Technical Officer $280K +$302K Jul 29, 2025
Bruce Turner Chief Strategy Officer $250K Aug 9, 2024
Michael Lefenfeld Director $241K Jun 8, 2023
Robert Lechleider Chief Medical Officer $150K +$150K Jul 29, 2025
Bob Lapetina PAO and VP Finance & Corporate $71.2K Jan 2, 2024
Jack Higgins Chief Scientific Officer $55K Sep 10, 2025
James P. Boylan Director Jun 10, 2025
Philip Wagenheim Director Jun 10, 2025
Isaac Barchas Director Jun 10, 2025
Carol Schafer Director Jun 10, 2025
Sandra Stoneman Chief Legal Officer & Gc Jul 29, 2025
Purnanand D. Sarma President and CEO, Director Jun 8, 2023
Phil Noland Roberts Chief Technology Officer Dec 13, 2023
Dennis H. Giesing Chief Development Officer Jun 8, 2023
Corleen Roche Chief Financial Officer Jun 8, 2023
Michael Widlitz Director May 28, 2021
Matthew K. Robinson Chief Technology Officer Jun 8, 2023
Richard A. Baron Director Jun 8, 2023
Sandra M. Swain Director Jun 10, 2025
Kinney Horn Chief Business Officer Jul 29, 2025

Recent Insider Transactions by Companies or Individuals for Immunome Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.